Macrophage stimulating protein promotes liver metastases of small cell lung cancer cells by affecting the organ microenvironment

Clinical and Experimental Metastasis

Volumn 30, Issue 3, 2013, Pages 333-344

  Sato, Seidai ^a   Hanibuchi, Masaki ^a   Kuramoto, Takuya ^a   Yamamori, Nodoka ^a   Goto, Hisatsugu ^a   Ogawa, Hirohisa ^a   Mitsuhashi, Atsushi ^a   Van, Trung The ^a   Kakiuchi, Soji ^a   Akiyama, Shin Ichi ^a   Nishioka, Yasuhiko ^a   Sone, Saburo ^a  

^a UNIVERSITY OF TOKUSHIMA   (Japan)

Author keywords

Liver metastasis; Macrophage stimulating protein; Organ microenvironment; Small cell lung cancer

Indexed keywords

MACROPHAGE STIMULATING PROTEIN; PROTEIN; UNCLASSIFIED DRUG; ONCOPROTEIN; PRIMER DNA; SCATTER FACTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BONE METASTASIS; CANCER CELL CULTURE; CAPILLARY DENSITY; CELL MOTILITY; CELL PROLIFERATION; CONTROLLED STUDY; ENDOTHELIUM CELL; GENETIC TRANSDUCTION; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; LIVER METASTASIS; LUNG METASTASIS; MACROPHAGE; MALE; MOUSE; NONHUMAN; ANIMAL; GENETICS; LIVER TUMOR; LUNG TUMOR; METASTASIS; MOUSE MUTANT; NUCLEOTIDE SEQUENCE; PATHOLOGY; PHYSIOLOGY; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TUMOR CELL LINE; TUMOR MICROENVIRONMENT; WESTERN BLOTTING;

ANIMALS; BASE SEQUENCE; BLOTTING, WESTERN; CELL LINE, TUMOR; CELL PROLIFERATION; DNA PRIMERS; HEPATOCYTE GROWTH FACTOR; HUMANS; LIVER NEOPLASMS; LUNG NEOPLASMS; MICE; MICE, SCID; PROTO-ONCOGENE PROTEINS; REAL-TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TRANSDUCTION, GENETIC; TUMOR MICROENVIRONMENT;

MLCS; MLOWN;

EID: 84875792986     PISSN: 02620898     EISSN: 15737276     Source Type: Journal    
DOI: 10.1007/s10585-012-9540-y     Document Type: Article

References (35)

1. Sone S, Yano S (2007) Molecular pathogenesis and its therapeutic modalities of lung cancer metastasis to bone. Cancer Metastasis Rev 26:685-689
2. Skeel A, Yoshimura T, Showalter SD, Tanaka S, Appella E, Leonard EJ (1991) Macrophage stimulating protein: purification, partial amino acid sequence, and cellular activity. J Exp Med 173:1227-1234
3. Bezerra JA, Witte DP, Aronow BJ, Degen SJ (1993) Hepatocyte-specific expression of the mouse hepatocyte growth factor-like protein. Hepatology 18:394-399
4. Yoshimura T, Yuhki N, Wang MH, Skeel A, Leonard EJ (1993) Cloning, sequencing, and expression of human macrophage stimulating protein (MSP, MST1) confirms MSP as a member of the family of kringle proteins and locates the MSP gene on chromosome 3. J Biol Chem 268:15461-15468
5. Wang MH, Skeel A, Leonard EJ (1996) Proteolytic cleavage and activation of pro-macrophage-stimulating protein by resident peritoneal macrophage membrane proteases. J Clin Invest 97:720-727
6. Nanney LB, Skeel A, Luan J, Polis S, Richmond A, Wang MH, Leonard EJ (1998) Proteolytic cleavage and activation of pro-macrophage-stimulating protein and upregulation of its receptor in tissue injury. J Invest Dermatol 111:573-581
7. Ronsin C, Muscatelli F, Mattei MG, Breathnach R (1993) A novel putative receptor protein tyrosine kinase of the met family. Oncogene 8:1195-1202
8. Gaudino G, Follenzi A, Naldini L, Collesi C, Santoro M, Gallo KA, Godowski PJ, Comoglio PM (1994) RON is a heterodimeric tyrosine kinase receptor activated by the HGF homologue MSP. EMBO J 13:3524-3532
9. Iwama A, Yamaguchi N, Suda T (1996) STK/RON receptor tyrosine kinase mediates both apoptotic and growth signals via the multifunctional docking site conserved among the HGF receptor family. EMBO J 15:5866-5875
10. Peace BE, Hughes MJ, Degen SJ, Waltz SE (2001) Point mutations and overexpression of Ron induce transformation, tumor formation, and metastasis. Oncogene 20:6142-6151
11. Kretschmann KL, Eyob H, Buys SS, Welm AL (2010) The macrophage stimulating protein/Ron pathway as a potential therapeutic target to impede multiple mechanisms involved in breast cancer progression. Curr Drug Targets 11:1157-1168
12. Welm AL, Sneddon JB, Taylor C, Nuyten DS, van de Vijver MJ, Hasegawa BH, Bishop JM (2007) The macrophage-stimulating protein pathway promotes metastasis in a mouse model for breast cancer and predicts poor prognosis in humans. Proc Natl Acad Sci U S A 104:7570-7575
13. Kakiuchi S, Daigo Y, Tsunoda T, Yano S, Sone S, Nakamura Y (2003) Genome-wide analysis of organ-preferential metastasis of human small cell lung cancer in mice. Mol Cancer Res 1:485-499
14. Kiura K, Watarai S, Shibayama T, Ohnoshi T, Kimura I, Yasuda T (1993) Inhibitory effects of cholera toxin on in vitro growth of human lung cancer cell lines. Anticancer Drug Des 8:417-428
15. Otsuka S, Hanibuchi M, Ikuta K, Yano S, Goto H, Ogino H, Yamada T, Kakiuchi S, Nishioka Y, Takahashi T, Sone S (2009) A bone metastasis model with osteolytic and osteoblastic properties of human lung cancer ACC-LC-319/bone2 in natural killer cell-depleted severe combined immunodeficient mice. Oncol Res 17:581-591
16. Morita S, Kojima T, Kitamura T (2000) Plat-E: an efficient and stable system for transient packaging of retroviruses. Gene Ther 7:1063-1066
17. Tanaka T, Kitamura F, Nagasaka Y, Kuida K, Suwa H, Miyasaka M (1993) Selective long-term elimination of natural killer cells in vivo by an anti-interleukin-2 receptor β chain monoclonal antibody in mice. J Exp Med 178:1103-1107
18. Yano S, Zhang H, Hanibuchi M, Miki T, Goto H, Uehara H, Sone S (2003) Combined therapy with a new bisphosphonate, minodronate (YM529), and chemotherapy for multiple organ metastases of small cell lung cancer cells in severe combined immunodeficient mice. Clin Cancer Res 9:5380-5385
19. Green LM, Reade JL, Ware CF (1984) Rapid colometric assay for cell viability: application to the quantitation of cytotoxic and growth inhibitory lymphokines. J Immunol Methods 70:257-268
20. Yano S, Nishioka Y, Izumi K, Tsuruo T, Tanaka T, Miyasaka M, Sone S (1996) Novel metastasis model of human lung cancer in SCID mice depleted of NK cells. Int J Cancer 67:211-217
21. Miki T, Yano S, Hanibuchi M, Sone S (2000) Bone metastasis model with multiorgan dissemination of human small-cell lung cancer (SBC-5) cells in natural killer cell-depleted SCID mice. Oncol Res 12:209-217
22. Willett CG, Wang MH, Emanuel RL, Graham SA, Smith DI, Shridhar V, Sugarbaker DJ, Sunday ME (1998) Macrophage-stimulating protein and its receptor in non-small-cell lung tumors: induction of receptor tyrosine phosphorylation and cell migration. Am J Respir Cell Mol Biol 18:489-496
23. Kawaguchi M, Orikawa H, Baba T, Fukushima T, Kataoka H (2009) Hepatocyte growth factor activator is a serum activator of single-chain precursor macrophage-stimulating protein. FEBS J 13:3481-3490
24. Liotta LA, Kohn EC (2001) The microenvironment of the tumor-host interface. Nature 411:375-379
25. Fidler IJ (2002) The organ microenvironment and cancer metastasis. Differentiation 70:498-505
26. Takanami I, Takeuchi K, Kodaira S (1999) Tumor-associated macrophage infiltration in pulmonary adenocarcinoma: association with angiogenesis and poor prognosis. Oncology 57:138-142
27. Wagh PK, Peace BE, Waltz SE (2008) Met-related receptor tyrosine kinase Ron in tumor growth and metastasis. Adv Cancer Res 100:1-33
28. Iida I, Johkura K, Teng R, Kubota S, Cui L, Zhao X, Ogiwara N, Okouchi Y, Asanuma K, Nakayama J, Sasaki K (2003) Immunohistochemical localization of hepatocyte growth factor activator (HGFA) in developing mouse liver tissues. Heterogeneous distribution of HGFA protein. J Histochem Cytochem 9:1139-1149
29. Nanashima A, Shibata K, Nakayama T, Tobinaga S, Araki M, Kunizaki M, Takeshita H, Hidaka S, Sawai T, Nagayasu T, Yasutake T (2009) Clinical significance of microvessel count in patients with metastatic liver cancer originating from colorectal carcinoma. Ann Surg Oncol 16:2130-2137
30. van der Wal GE, Gouw AS, Kamps JA, Moorlag HE, Bulthuis ML, Molema G, de Jong KP (2012) Angiogenesis in synchronous and metachronous colorectal liver metastases: the liver as a permissive soil. Ann Surg 255:86-94
31. Gabr AG, Goto H, Hanibuchi M, Ogawa H, Kuramoto T, Suzuki M, Saijo A, Kakiuchi S, Trung VT, Sakaguchi S, Moriya Y, Sone S, Nishioka Y (2012) Erlotinib prevents experimental metastases of human small cell lung cancer cells with no epidermal growth factor receptor expression. Clin Exp Metastasis (in press)
32. Wang D, Shen Q, Chen YQ, Wang MH (2004) Collaborative activities of macrophage-stimulating protein and transforming growth factor-β1 in induction of epithelial to mesenchymal transition: roles of the RON receptor tyrosine kinase. Oncogene 23:1668-1680
33. Lee WY, Chen HH, Chow NH, Su WC, Lin PW, Guo HR (2005) Prognostic significance of co-expression of RON and MET receptors in node-negative breast cancer patients. Clin Cancer Res 11:2222-2228
34. Kanteti R, Krishnaswamy S, Catenacci D, Tan YH, El-Hashani E, Cervantes G, Husain AN, Tretiakova M, Vokes EE, Huet H, Salgia R (2012) Differential expression of RON in small and non-small cell lung cancers. Genes Chromosomes Cancer 51:841-851
35. O'Toole JM, Rabenau KE, Burns K, Lu D, Mangalampalli V, Balderes P, Covino N, Bassi R, Prewett M, Gottfredsen KJ, Thobe MN, Cheng Y, Li Y, Hicklin DJ, Zhu Z, Waltz SE, Hayman MJ, Ludwig DL, Pereira DS (2006) Therapeutic implications of a human neutralizing antibody to the macrophage-stimulating protein receptor tyrosine kinase (RON), a c-MET family member. Cancer Res 66:9162-9170